PPT-Reducing the burden of cervical cancer

Dr Reynier Ter Haar Mrs Beatrice Kabota Nkhoma Hospital and University of Edinburgh 29 August 2016 Lilongwe Malawi Cancer Symposium 1 Aim To explain Nkhoma hub and spokes model . Arkansas Statistics. Nancy Andrews Collins, M.D., MBA. Associate Professor. Department of Obstetrics and Gynecology. College of Medicine. University of Arkansas for Medical Sciences (UAMS). Ovarian Cancer. George . Sikivou. What Is . I. t?. The cancer of the cervix, which is caused mainly by the Human Papilloma Virus (HPV). 70% of cervical cancers and precancerous cervical lesions are caused by Types 16, 18.. The Obstetrics & Gynecological Society of Bhopal. &. AMPOGS Research Public Welfare Society. BREAST . AND GENITAL TRACT CANCER INCIDENCE RATES PER 100,000 . FEMALES worldwide. 31.3. 17.4. 8.3. Cervical Cancer Statistics. United . States. An estimated 12,000 new cases each year. An estimated 4,000 . deaths . each year . 700,000 cases of severe . pre-cancer . International. Approximately 500,000 cases expected worldwide each year!. Annual CPCRN Meeting, Chicago. Tuesday, May 24. th. . Lead: Karen Glanz, PhD, MPH. Participating Sites: . UPenn. , UNC, . UWash. , CDC, NCI. This presentation was supported by Cooperative Agreement Number U48 DP005053 from the Centers for Disease Control and Prevention. The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. . 141. st. APHA Annual Meeting. November 2013. Richard A. Crosby, PhD. University of Kentucky College of Public Health. Department of Health Behavior. . Presenter Disclosures. (1) The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months:. By Beshair Nurhussien, Agnes Nantambi, and Allison Wood. Worcester Technical High, Doherty Memorial, Doherty Memorial. 1. Health Disparity. “Difference in the incidence, prevalence mortality, and other adverse health conditions that exist among specific population groups.” . Presented by:. The Foundation for Women’s . Cancer. © . Updated September 2012. About this . presentation. This presentation is intended to help women take an active role in their health care. It does not replace the judgment of a health care professional in diagnosing and treating disease.. A Resident’s Primer. Presented as an education exhibit at the 2014 RSNA Annual Meeting – OBE117.. All authors have disclosed no relevant relationships.. Anish . Raithatha. , BSc, MBBS,. 1*. . Ioanna. Megan Swanson, MD MPH. Assistant Professor. Gynecologic Oncology. UCSF. Limited effective treatment options for advanced cervical cancer. Problem. : when cervical cancer is . advanced. and/or recurrent . Dr. Seema Singhal . Department of Obstetrics and . Gynaecology. . AIIMS New Delhi . Cervical cancer disease burden . Global Incidence and mortality in 2018 . India : Major contributor to global burden of cervical cancer . CERVICAL CANCER. 4th most common cancer in women worldwide. CERVICAL CANCER. 4th most common cancer in women worldwide. >250,000 deaths/year. CERVICAL CANCER. 4th most common cancer in women worldwide. Selemawit. Ghebrendrias. 1. , Sarah Pfeil. 1. , Sheila K. Mody. 1. , Bonnie Crouthamel. 1. , Morgen Chalmiers. 1. , . Gennifer. Kully. 1. 1. Division Of Family Planning, Department Of Obstetrics, Gynecology, And Reproductive Sciences, University Of California, San Diego. Utah Academy of Family Physicians, 11/7/20. Clara . Keegan, . MD, FAAFP. University of Vermont Department of Family Medicine. After this activity, I hope you will be able to …. Summarize the natural history of HPV as it relates to cervical cancer screening..